The ever‐growing pursuit of high energy density batteries has triggered extensive efforts toward developing alkali metal (Li, Na, and K) battery (AMB) technologies owing to high theoretical capacities and low redox potentials of metallic anodes. Typically, for new battery systems, the electrolyte design is critical for realizing the battery electrochemistry of AMBs. Conventional electrolytes in alkali ion batteries are generally unsuitable for sustaining the stability owing to the hyper‐reactivity and dendritic growth of alkali metals. In this review, we begin with the fundamentals of AMB electrolytes. Recent advancements in concentrated and fluorinated electrolytes, as well as functional electrolyte additives for boosting the stability of Li metal batteries, are summarized and discussed with a special focus on structure–composition–performance relationships. We then delve into the electrolyte formulations for Na‐ and K metal batteries, including those in which Na/K do not adhere to the Li‐inherited paradigms. Finally, the challenges and the future research needs in advanced electrolytes for AMB are highlighted. This comprehensive review sheds light on the principles for the rational design of promising electrolytes and offers new inspirations for developing stable AMBs with high performance.

No abstract

No abstract

No abstract

Introduction: Enteral feed is an important component of nutritional therapy in critically ill patients and underfeeding has been associated with adverse outcomes. The article developed an enteral feeding protocol and planed a before-and-after comparative trial to explore whether implementation of enteral feeding protocol was able to improve clinical outcomes. Methods and analysis:The study will be conducted in intensive care units (ICUs) of ten tertiary care academic centers. Critically ill patients expected to stay in ICU for over 3 days and require enteral nutrition (EN) were potentially eligible. This is a before-and-after study comprising three phases: The first phase is the period without enteral feeding protocol; the second phase involves four-week training program, and the last phase is to perform the protocol in participating centers. We plan to enroll a total of 350 patients to provide an 80% power and 0.05 error rate to detect a 15% reduction of mortality. The primary outcome is 28-day mortality.Ethics and dissemination: Ethical approval to conduct the research has been obtained from all participating centers. Additionally, the results will be published in peer-reviewed journal.Trial registration: The study was registered at International Standard Registered Clinical/soCial sTudy Number (ISRCTN) registry (ISRCTN10583582).